MTOR and cancer: When this inhibitory role is disrupted, RTK activation triggers the phosphorylation of downstream components, initiating multiple signaling cascades including PI3K-Akt-mTOR and JAK-STAT pathways, which are frequently dysregulated in cancer (Fig. 4).